Enhancer provides a potential target for ‘undruggable’ MYC in pediatric medulloblastoma (IMAGE)

St. Jude Children's Research Hospital

Enhancer provides a potential target for ‘undruggable’ MYC in pediatric medulloblastoma

Caption

Corresponding author Martine Roussel, PhD, St. Jude Department of Tumor Cell Biology, and first author Jake Friske, St. Jude Graduate School of Biomedical Sciences.

Credit

St. Jude Children's Research

Usage Restrictions

No cropping

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.